期刊文献+

门诊处方点评与分析

Comment and analysis of outpatient prescriptions
暂未订购
导出
摘要 目的通过对处方进行点评分析,了解处方基本情况和存在的问题,规范处方书写和促进合理用药。方法以随机抽样法抽取某院2012年1~12月门诊处方4080张逐一点评,分类统计基本用药指标和汇总点评结果进行分析。结果平均每张处方用药2.74种,平均每张处方金额128.32元,抗菌药物使用率为29.63%,注射剂使用率为22.54%,药品通用名使用率为98.42%,基本药物使用率为41.69%,不合格处方281张,占抽查处方数的6.89%,其中不规范处方173张,用药不适宜处方94张,超常处方14张,分别占不合理处方数的61.57%、33.45%、4.98%。结论某院门诊处方基本合理、规范,对存在的问题,医院还须加强管理和干预,进一步提高医师合理用药、书写处方和药师审核处方的水平,进而提高处方质量。 Objective To probe into basic situation and existing problems in outpatient prescriptions through comment and analysis of the outpatient prescriptions so as to standardize prescription writing and improve rational drug use. Methods A total of 4080 outpatient prescriptions from January to December, 2012 of some hospital were randomly selected, reviewed one by one, and analyzed by classification statistic of basic drug indicators and summary of comment results. Results Of the 4080 prescriptions reviewed, an average of 2.74 drugs was used per prescription and the average cost of each one was 128.32 Yuan. 29.63% of the prescriptions prescribed antibiotics, 22.54% injections, 98.42% drugs in generic names, and 41.69% prescribed essential drugs. 281(6.89%) were unreasonable in which 173 were nonstandard, 94 inappropriate in drug use and 14 had off-label use, which accounted for 61.57%, 33.45%, 4.98% of all unreasonable prcscriptions respectively. Conclusion The prescription of the hospital outpatient department was rational and standard on the whole. Yet there remain some problems. The hospital needs to strengthen the management and intervention, to further improve physicians rational drug use, prescription- writing and the pharmacists audit level of prescriptions, so as to improve the quality of prescriptions.
作者 赵曙刚
出处 《中国医药科学》 2013年第20期142-144,共3页 China Medicine And Pharmacy
关键词 处方点评 处方分析 合理用药 Prescription comment Prescription analysis Rational drug use
  • 相关文献

参考文献9

二级参考文献35

  • 1曾繁典.抗生素及合成抗菌药物的滥用与危害[J].中国药物警戒,2004,1(1):25-27. 被引量:72
  • 2唐镜波,陈香谱,谭军,车艳.合理用药调研的国际指标[J].中国药房,1995,6(4):5-7. 被引量:176
  • 3Radley DC, Finkelstein SN, Stafford RS. Off- la-bel prescribing among office based physicians [ J ]. Arch Intern Med, 2006, 166(9) :1021 - 1026.
  • 4Eastman P. Reimbursement policies discourage off - label drug use [ J ]. Oncology Times, 2005, 27 (20) :8 - 10.
  • 5Kocs D, Fendrick AM. Effect of off - label use of oncology drugs on pharmaceutical costs: the ritux- imab experience [ J ]. Am J Manag Care, 2003,9 (5) :393 -400.
  • 6Strode, A. E. , Slack, C. M., Wassenaar, D. R. ,et al. One step forward, two steps back -requiting min- isterial approval for all "non- therapeutic" health research involving minors [ J ]. S Mr Med J, 2007, 97 (3) :200 -202.
  • 7国家食品药品监督管理局.警惕阿昔洛韦导致急性肾功能损害(第19期药品不良反应信息通报)[EB/OL].http://www.sda.gov.cn/ws01/CL0078/35214.html.2009-01-12/2010-11-10.
  • 8国家食品药品监督管理局.关注穿琥宁和炎琥宁注射剂的安全性问题(第23期药品不良反应信息通报)[EB/OL].http://www.sda.gov.cn/WS01/CL0078/41077.html.2009-01-12/2010-11-10.
  • 9上海55例患者眼科治疗引起不良反应[EB/OL].http://news.xinhuanet.corn/heath/2010-09/10/c_12537643.htm,2010-09-10/2010-11-10.
  • 10World Health Organization. Promoting Rational Use of Medicines:Core Components, September 2002, Geneva.

共引文献453

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部